Hepion Pharmaceuticals Inc (NASDAQ:HEPA)

2.30
Delayed Data
As of Jan 15
 -0.04 / -1.71%
Today’s Change
1.00
Today|||52-Week Range
6.90
+5.02%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Hepion Pharmaceuticals Inc have a median target of 8.00, with a high estimate of 8.00 and a low estimate of 8.00. The median estimate represents a +247.83% increase from the last price of 2.30.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Hepion Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.20
Sales
$0.00
Reporting Date
Mar 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 71.01%
 
 
 
 
 
 
Growthannually 62.38%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.